Since weight loss is typically associated with muscle loss, the concern with GLP-1 drugs is whether these medications induce excessive muscle loss than expected for the achieved decline in weight
"Lilly is in a unique position to work with the U.S
In a research log or simple spreadsheet, note the peptide name, reconstitution date, bacteriostatic water used, volume added, resulting concentration, storage location, and expected discard date
Specifically, 11 RCTs assessed the glucose-lowering effect of GLP-1 RAs combined with basal insulin versus GLP-1 RA monotherapy [507-517], while 25 RCTs evaluated this combination against basal insulin monotherapy [509,510,518,519]